A Study to Assess New Formulations of TEV-56286

Clinical trial NCT06911567 · COMPLETED

Trial details

NCT number: NCT06911567
Sponsor: Teva Branded Pharmaceutical Products R&D LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2025-03-10
Primary completion: 2025-05-22
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.